We also identified differentially hydroxymethylated sites in the promoter and distal enhancer-like signature (dELS) regions of GRIN2A, an important regulator of glutamate signaling that has been well associated with bipolar disorder (99). The gene discussed is GRIN2A; the disease is bipolar disorder.